This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,548.07 contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price arrangement with a ceiling value of $4,734.26 and an ultimate completion date of August 20, 2024. The contract is not set aside for any specific business category. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,511.44 and a completion date of January 12, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 380 mg vials of Vivitrol, a medication used to treat opioid dependence. The contract is a firm-fixed price delivery order with a ceiling value of $16,058.67 and a performance period ending on September 5, 2024. AmerisourceBergen has been awarded multiple indefinite-delivery contracts (IDCs) with the DLA and other federal agencies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.91, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The contract has an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,224.46 firm fixed-price contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 19, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $5,485.86 firm fixed-price contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a completion date of July 18, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has a significant...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,742.93 and is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract is a firm fixed price agreement with an ultimate completion date of August 27, 2024.
AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, with a ceiling value of $3,657.24 and a completion date of July 25, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed-price pricing structure and a ceiling value of $6,305.54. The ultimate completion date is July 25, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...